CN116348498A - 多肽、多聚体、固相、受试物质的测定方法及试剂盒 - Google Patents
多肽、多聚体、固相、受试物质的测定方法及试剂盒 Download PDFInfo
- Publication number
- CN116348498A CN116348498A CN202180070129.8A CN202180070129A CN116348498A CN 116348498 A CN116348498 A CN 116348498A CN 202180070129 A CN202180070129 A CN 202180070129A CN 116348498 A CN116348498 A CN 116348498A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- biotin
- polypeptide
- streptavidin
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020174961 | 2020-10-16 | ||
| JP2020-174961 | 2020-10-16 | ||
| PCT/JP2021/038254 WO2022080486A1 (ja) | 2020-10-16 | 2021-10-15 | ポリペプチド、多量体、固相、被検物質の測定方法および試薬キット |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116348498A true CN116348498A (zh) | 2023-06-27 |
Family
ID=81208108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180070129.8A Pending CN116348498A (zh) | 2020-10-16 | 2021-10-15 | 多肽、多聚体、固相、受试物质的测定方法及试剂盒 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230288411A1 (https=) |
| EP (1) | EP4230643A4 (https=) |
| JP (1) | JPWO2022080486A1 (https=) |
| CN (1) | CN116348498A (https=) |
| WO (1) | WO2022080486A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023132075A (ja) * | 2022-03-10 | 2023-09-22 | シスメックス株式会社 | L-ビオチン測定用試薬、l-ビオチンを含む試料の測定方法、l-ビオチン標識された物質の標識数の決定方法、及び光学異性アビジン類が固定化された固相の製造方法 |
| EP4522281A2 (en) * | 2022-05-13 | 2025-03-19 | University of Utah Research Foundation | Biotin orthogonal streptavidin system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103025875A (zh) * | 2010-08-30 | 2013-04-03 | 霍夫曼-拉罗奇有限公司 | 原核表达构建体 |
| US20160137704A1 (en) * | 2013-02-20 | 2016-05-19 | Savid Therapeutics Inc. | Modified biotin, mutant streptavidin, and use thereof |
| CN111032850A (zh) * | 2017-04-27 | 2020-04-17 | 朱诺治疗学有限公司 | 寡聚粒子试剂及其使用方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2606722B2 (ja) | 1988-04-05 | 1997-05-07 | 栄治 石川 | 超高感度抗原物質の測定法 |
| WO1995015978A1 (en) * | 1993-12-07 | 1995-06-15 | Neorx Corporation | Pretargeting methods and compounds |
| JP3277071B2 (ja) * | 1994-04-27 | 2002-04-22 | キッコーマン株式会社 | 変異型ストレプトアビジン遺伝子、変異型ストレプトアビジン−ホタルルシフェラーゼ融合蛋白質遺伝子、新規な組み換え体dna及びストレプトアビジン−ホタルルシフェラーゼ融合蛋白質の製造法 |
| JPH1010359A (ja) * | 1996-06-21 | 1998-01-16 | Ando Electric Co Ltd | 光結合器 |
| EP0977770A4 (en) * | 1997-03-14 | 2000-04-05 | Univ Boston | DIFFERENTLY FLAVORED STREPTAVIDINE |
| EP1369476B1 (en) | 2001-03-12 | 2010-07-21 | Japan Tobacco Inc. | A novel protein, a gene encoding therefor and a method of using the same |
| JP4228072B2 (ja) * | 2003-06-04 | 2009-02-25 | 独立行政法人農業・食品産業技術総合研究機構 | アビジンをコードする人工合成遺伝子 |
| WO2006058226A2 (en) | 2004-11-24 | 2006-06-01 | The Trustees Of Boston University | Modified dimeric streptavidins and uses thereof |
| GB0919102D0 (en) * | 2009-10-30 | 2009-12-16 | Isis Innovation | Streptavidin mutant proteins |
| WO2011158798A1 (ja) * | 2010-06-14 | 2011-12-22 | 国立大学法人山口大学 | 乾癬治療効果の経過観察及び早期の予測方法並びにそれらに使用するキット |
| WO2013018836A1 (ja) * | 2011-08-01 | 2013-02-07 | 日本たばこ産業株式会社 | 生物学的試料中の物質を検出する工程において、非特異的結合を抑制する方法、当該方法に使用するための剤 |
| JP7153460B2 (ja) * | 2018-03-30 | 2022-10-14 | シスメックス株式会社 | リポタンパク質の取り込み能を測定する方法及び試薬 |
-
2021
- 2021-10-15 JP JP2022557482A patent/JPWO2022080486A1/ja active Pending
- 2021-10-15 CN CN202180070129.8A patent/CN116348498A/zh active Pending
- 2021-10-15 WO PCT/JP2021/038254 patent/WO2022080486A1/ja not_active Ceased
- 2021-10-15 EP EP21880221.3A patent/EP4230643A4/en active Pending
-
2023
- 2023-04-13 US US18/299,833 patent/US20230288411A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103025875A (zh) * | 2010-08-30 | 2013-04-03 | 霍夫曼-拉罗奇有限公司 | 原核表达构建体 |
| US20160137704A1 (en) * | 2013-02-20 | 2016-05-19 | Savid Therapeutics Inc. | Modified biotin, mutant streptavidin, and use thereof |
| CN111032850A (zh) * | 2017-04-27 | 2020-04-17 | 朱诺治疗学有限公司 | 寡聚粒子试剂及其使用方法 |
Non-Patent Citations (2)
| Title |
|---|
| JOHN H T LUONG等: "Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat", 《BIOTECHNOL ADV.》, vol. 37, no. 5, 11 March 2019 (2019-03-11), pages 634 - 641 * |
| LE ZHAO等: "Mirror image proteins", 《CURR OPIN CHEM BIOL.》, vol. 22, 1 October 2014 (2014-10-01), pages 56 - 61 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2022080486A1 (https=) | 2022-04-21 |
| WO2022080486A1 (ja) | 2022-04-21 |
| EP4230643A1 (en) | 2023-08-23 |
| US20230288411A1 (en) | 2023-09-14 |
| EP4230643A4 (en) | 2025-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100586959C (zh) | 具有与钛、银、硅结合能力的肽 | |
| US20230251265A1 (en) | Preparation method and the application of capture magnetic bead targeting weak protein-protein interactions based on the photo-affinity covalent linkage strategy | |
| KR101104417B1 (ko) | 단백질 g 변형체를 이용한 항체의 특이적 공유결합 커플링방법 | |
| CN116355092B (zh) | 抗人血清白蛋白的纳米抗体及其应用 | |
| US20230288411A1 (en) | Polypeptide, multimer, solid phase, measurement method for test substance, and reagent kit | |
| JPH04505857A (ja) | C反応性蛋白質に対するモノクローナル抗体 | |
| AU2001275975B2 (en) | Method for immuno-detection of epitopes | |
| CA1341014C (en) | Hcg peptides for use in antibody purification procedures | |
| CN110456053A (zh) | 一种二价靶向多肽探针及其制备方法 | |
| JP6818305B2 (ja) | 非天然型立体構造を形成した抗体に親和性を示すポリペプチド | |
| CN119119183A (zh) | 靶向pd-l1的小分子多肽及应用 | |
| CN116284424A (zh) | 抗鼠抗体可结晶段的纳米抗体及其应用 | |
| EP4242660A1 (en) | Reagent for measuring l-biotin, method for measuring sample containing l-biotin, method for determining number of labels of l-biotin-labeled substance, and method for producing solid phase on which optically isomeric biotin-binding site is immobilized | |
| JP2010122002A (ja) | 抗体の検出方法及び該方法に用いられる試薬キット | |
| WO2021256524A1 (ja) | 免疫原性低減型低分子抗体とその製造法 | |
| EP3523327B1 (en) | Peptides for binding epidermal growth factor | |
| RU2062473C1 (ru) | Иммунометрический способ определения хорионического гонадотропина человека | |
| Møller et al. | Peptide Tags for Site‐Selective Nonenzymatic Covalent Modification of Proteins | |
| JP2002014102A (ja) | タンパク質の検出方法、プローブペプチドおよびインシュリンの検出方法 | |
| JP2026505450A (ja) | 一本鎖抗体断片の化学合成法およびそれにより得られる物 | |
| JP4618751B2 (ja) | ルシフェラーゼに対して結合性を有するペプチド | |
| CN117264076A (zh) | 标记多肽、修饰多肽、这些多肽的制造方法、含这些多肽的试剂及目标物质的测定方法 | |
| Iwamoto | Synthesis of Functional Characterization of Protein Domains for the Development of Mirror-Image Therapeutics | |
| KR101809135B1 (ko) | 형광면역측정용 키트 및 이를 이용하여 질병을 진단하는 방법 | |
| JP2025096496A (ja) | IgG結合ペプチドを用いたIgG抗体の部位特異的修飾体を用いた免疫測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |